Trial FAQs
Who can participate?
- Patients age 12+ who have been diagnosed with Hidradenitis Suppurativa (HS)
How long will the study last?
Approximately 67 weeks.
What are the benefits?
- No cost to participate or receive study treatment
- Regular visits with study dermatologists
What is the inclusion criteria?
- Diagnosis of HS for at least 6 months
- At least 2 different areas affected
- Willing/able to adhere to study visits and monitoring
Clinical Trial for Hidradenitis Suppurativa (HS)
Patient Treatment Innovations
Clinical research trials serve as the avenue to allow these treatments and medications to eventually reach the public. Clinical trials involve human volunteer patients, allowing them to receive investigational treatments- a new drug or device. Trials are closely monitored by specialized physicians and are the primary way researchers can evaluate safety, efficacy, benefits and effectiveness of new treatments.
Dr. Yadav is proud to be at the forefront of dermatological research. In partnership with Probity Medical Research, one of the most highly regarded and renowned clinical research organizations across Canada and the United States, Dr. Yadav can offer patients the opportunity to participate in trials that have the newest and most advanced investigational treatments in dermatology.